Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BMS 981164

Next Previous
Drug Profile

BMS 981164

Alternative Names: BMS981164; IL-31 mAB - Bristol-Myers Squibb; IL-31 monoclonal antibody - Bristol-Myers Squibb

Latest Information Update: 19 Apr 2016

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ZymoGenetics
  • Developer Bristol-Myers Squibb; ZymoGenetics
  • Class Monoclonal antibodies; Skin disorder therapies
  • Mechanism of Action Interleukin 31 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Atopic dermatitis; Inflammation

Most Recent Events

  • 01 Apr 2015 Bristol-Myers Squibb completes a phase I trial in Atopic dermatitis in United Kingdom (NCT01614756)
  • 16 Apr 2014 Bristol-Myers Squibb initiates enrolment in a phase I trial for Atopic dermatitis in United kingdom (UKCRN13421)
  • 01 Jul 2012 Phase-I clinical trials in Atopic dermatitis in United Kingdom (SC, IV) (NCT01614756)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top